Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis

Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis

Hongxiang Wei,1,* Fei Chen,1,* Jinyuan Chen,2,* Huangfeng Lin,1 Shenglin Wang,1 Yunqing Wang,1 Chaoyang Wu,1 Jianhua Lin,1 Guangxian Zhong1 1Department of Orthopaedics, Fujian Institute of Orthopaedics, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 35000...

Full description

Bibliographic Details
Main Authors: Wei H, Chen F, Chen J, Lin H, Wang S, Wang Y, Wu C, Lin J, Zhong G
Format: Article
Language:English
Published: Dove Medical Press 2022-08-01
Series:International Journal of Nanomedicine
Subjects:
targeted therapy
exosome
doxorubicin
osteosarcoma
nanocarrier
Online Access:https://www.dovepress.com/mesenchymal-stem-cell-derived-exosomes-as-nanodrug-carrier-of-doxorubi-peer-reviewed-fulltext-article-IJN

Internet

https://www.dovepress.com/mesenchymal-stem-cell-derived-exosomes-as-nanodrug-carrier-of-doxorubi-peer-reviewed-fulltext-article-IJN

Similar Items